{
    "url": "https://nationalscreening.blog.gov.uk/2023/07/24/update-on-the-evaluative-rollout-of-nipt-in-england/",
    "title": "Update on the evaluative rollout of NIPT in England",
    "authors": [
        "Professor Anne Mackie",
        "Deborah Tomalin"
    ],
    "categories": [
        "General"
    ],
    "pub_date": "2023-07-24T10:21:13+01:00",
    "content": [
        {
            "text": "On 1 June 2021, following a positive UK NSC recommendation, non-invasive prenatal testing (NIPT) was added to the existing NHS screening programme for Down\u2019s syndrome, Edwards\u2019 syndrome and Patau\u2019s syndrome in England."
        },
        {
            "text": "The NIPT blood test is a second screening test offered to pregnant women whose initial combined or quadruple screening test result shows that their chance of having a baby with one of these 3 conditions is greater than 1 in 150."
        },
        {
            "text": "This means women who receive a higher chance result from a combined or quadruple test can choose one of 3 options:"
        },
        {
            "text": "Jane Fisher, Director \u2013 Antenatal Results and Choices (ARC):"
        },
        {
            "text": "The NHS started this evaluation despite facing many challenges brought about by the COVID-19 pandemic."
        },
        {
            "text": "The evaluation is working well due to the sheer dedication and commitment of midwives, antenatal screening coordinators and the genomic laboratories. We want to say a huge thank you for their hard work."
        },
        {
            "text": "Elizabeth Young, Principal Clinical Scientist \u2013 Birmingham Women's Hospital, Central and South Genomic Laboratory Hub:"
        },
        {
            "heading": 2,
            "text": "Initial results"
        },
        {
            "text": "The National Congenital Anomaly and Rare Disease Registration Service (NCARDRS) was set up in 2015 and collects data on congenital anomalies across England. NCARDRS supports the evaluative roll out of NIPT by collecting data from the biochemistry screening laboratories on combined and quadruple tests."
        },
        {
            "text": "Between 1 June 2021 and 30 September 2022 nearly 15,000 NIPT samples were tested across the 3 NIPT screening laboratories. About a fifth of NIPT tests followed a higher chance quadruple test and the rest followed a higher chance combined test result."
        },
        {
            "text": "A result was reported for 96% of these 15,000 samples. 86% of NIPT results were reported within 5 days. 7% of NIPT samples tested were reported as higher chance results for one or more of the 3 conditions."
        },
        {
            "text": "We also collect data directly from maternity services. Data so far shows:"
        },
        {
            "text": "Elsa Moro, Antenatal and Newborn screening coordinator \u2013 Guys & St Thomas\u2019 NHS Foundation Trust:"
        },
        {
            "heading": 2,
            "text": "e-learning and other resources"
        },
        {
            "text": "We would like to encourage all healthcare professionals who are involved in the offer of screening for\u00a0Down\u2019s syndrome, Edwards\u2019 syndrome and Patau\u2019s syndrome in England to complete the \u2018NIPT\u00a0\u2013 evaluative rollout\u2019 e-learning resource. In addition, we would ask screening coordinators to continue to use the higher chance information and resources."
        },
        {
            "text": "Please refer to the:"
        },
        {
            "text": "See also the operational guidance for healthcare professionals supporting the offer of NIPT"
        },
        {
            "heading": 2,
            "text": "UK NSC blog"
        },
        {
            "text": "The UK NSC blog provides up to date news from the UK NSC. You can\u00a0register\u00a0to receive updates direct to your inbox, so there\u2019s no need to keep checking for new articles. If you have any questions about this blog article, or about the work of the UK NSC, please email\u00a0screeninginformation@dhsc.gov.uk."
        }
    ]
}